Guardion Health Completes Delivery of $875,000 Order to Malaysian Corporate Customer
Guardion Health Sciences, Inc. ("Guardion" or the "Company") (NASDAQ: GHSI) announced today that it has completed shipment of Astramern to Astramune Sdn Bhd, a subsidiary of Ho Wah Genting Berhad ("HWGB") (KLSE:9601), a Malaysian compan
Benzinga · -
Guardion Health Sciences, Inc. ("Guardion" or the "Company") (NASDAQ: GHSI) announced today that it has completed shipment of Astramern to Astramune Sdn Bhd, a subsidiary of Ho Wah Genting Berhad ("HWGB") (KLSE:9601), a Malaysian company listed on the Malaysian Stock Exchange (Industrial Products sector). As such, the Company will recognize this shipment in operating revenues during the three months ending June 30, 2020. This order was previously announced by the Company on April 1, 2020. Astramern is a sister product to acuMMUNE™, the Company's proprietary immuno-supportive complex and the flagship product of the Company's recently-acquired NutriGuard™ business line. acuMMUNE™ and Astramem are novel nutraceutical formulations designed to support the body's immune function – including enhancing interferon-mediated anti-viral mechanisms and reducing the inflammation associated with certain respiratory infections. Additional information on acuMMUNE™ can be obtained at https://www.nutriguard.com/acummune/. Dr. David Evans, Ph.D., Guardion's interim President and Chief Executive Officer, commented, "We are pleased to announce the successful fulfillment of our first significant corporate order for our immune support product line. We believe that this demonstrates our ability to design, manufacture and deliver large-scale orders that originate from our NutriGuard™ brand, which was accomplished in spite of the operational and logistical challenges faced by traditional manufacturers in this current challenging business environment. Our team is continuing to evaluate other similar business opportunities in the Far East and elsewhere." Dr. Evans concluded. "I want to thank our entire team, and particularly Dr. Mark McCarty, the original founder of NutriGuard™, and now a senior scientist/consultant to Guardion, who led the development of this proprietary formulation."